Non-Invasive Prenatal Testing is a DNA test which is carried out on the maternal blood in order to screen fetal chromosomal anomalies. The gender of the fetus is also determined with the help of these DNA tests. Two NIPT tests, namely Panorama and NACE, are currently available in India. In 2015, Natera Inc. began offering its NIPT PanoramaTM in India. The test is facilitated in India by an agreement signed between Natera and MedGenome. As per the agreement, the company will develop the capacity and perform the Panorama test in India. Similarly, NACE, another Non-Invasive Prenatal Test, was introduced in October 2015 which has the ability to detect genetic abnormalities from the 10th week of gestation onwards, without creating any complications in the pregnancy. The results of the test are declared within 7-10 days of taking a sample. This test is highly accurate and it was launched in India by Igenomix.

According to new report by RNCOS, named, “Indian NIPT Market Outlook 2022”, the launch of two new NIPT tests in India has now enabled testing facility in India itself. Recently, Natera formed an alliance with Indian player for offering its test. By forming such alliances with large pathology service providers, the local players get the advantage of an already established network of blood collection centers, while partnering with gynecologists provide a low cost, low risk mean of sample collection. Besides, since gynecologists are the key influencers in the market, partnering with them prove numerous benefits to the players.

However, major challenge faced by the key players in this market is the relatively low awareness amongst Indian gynecologists and obstetricians about such tests. Some of the key initiatives taken in this direction include conducting conferences for gynecologists in key cities of New Delhi, Mumbai, Ahmedabad, Chennai and Bangalore; and spreading awareness about the benefits and technology of NIPT. Alternatively, players are also launching online marketing campaigns to spread awareness about the benefits of NIPT. They are also planning to focus on making an India specific website, wherein the NIPT can be suitably placed and promoted amongst the Indian consumers.

For FREE SAMPLE of this report visit: http://rncos.viewpage.co/Indian-NIPT-Market-Outlook-2022

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.